Palmitoylethanolamide in the Treatment of Failed Back Surgery Syndrome.

CONCLUSIONS: This observational study provides evidence, albeit preliminary, for the efficacy and safety of um-PEA (Normast) as part of a multimodal therapeutic regimen in the treatment of pain-resistant patients suffering from failed back surgery syndrome. PMID: 28875041 [PubMed]

https://www.ncbi.nlm.nih.gov/pubmed/28875041?dopt=Abstract

Source: Pain Research and Treatment - September 8, 2017 Category: Anesthesiology Tags: Pain Res Treat Source Type: research